Jon Askaa

Jon Askaa has worked in a variety of roles in the medical field. Jon began their career in 1985 as a Senior Principal Scientist at Dako. In 2007, they moved to Genentech as a Director of Companion Diagnostics. In 2009, they became a Consultant for Advanced Strategy in Companion Diagnostics and a Centre of Research & Education in General Practice at Region Zealand, University of Copenhagen, Denmark. In 2010, they were appointed CEO of MPI -Medical Prognosis Institute, and in 2012 they became the CMO of the same institute as well as a Non-executive Director for Inbiomotion SL.

Jon Askaa received their DVM and PhD from Den Kgl. Veterin\u00e6r- og Landboh\u00f8jskole in the years 1967 to 1983. Jon's field of study was Pathology-Virology-Immunology.